Geng-Long Hsu | Medicine and Dentistry | Best Researcher Award

Prof. Dr. Geng-Long Hsu | Medicine and Dentistry | Best Researcher Award

Director | Hsu’s Andrology | Taiwan

Prof. Dr. Geng-Long Hsu is a distinguished urologist and microsurgical potency reconstruction specialist with decades of experience in clinical practice, research, and education. He has pioneered innovative surgical techniques and contributed significant anatomical and physiological insights in male reproductive medicine. His leadership in multiple research centers and academic institutions has fostered a strong culture of mentorship and collaboration. Dr. Hsu is recognized internationally through memberships in professional societies and numerous awards for both basic and clinical research, highlighting the global impact of his work. His research demonstrates a consistent focus on advancing urological science, integrating clinical expertise with experimental innovation. Through his contributions, he has influenced treatment protocols and surgical outcomes in male reproductive health. His measurable research impact is reflected in Scopus, with 1,521 citations across 68 documents and an h-index of 22, underscoring the significance and reach of his scholarly work.

Profiles: Scopus | ORCID

Featured Publications

1. G.-L. Hsu, “Combining erection restoration and factual penile enhancement based on revolutionary penile fibro-vascular assembly,” Archivos Espanoles De Urologia, 2025.

2. G.-L. Hsu, “A detailed analysis of the penile fibro-vascular assembly,” Journal of Sexual Medicine, 2025.

3. G.-L. Hsu, “Coil embolization is not justified for treating patients with veno-occlusive dysfunction: Case series and narrative literature review,” Life, 2024.

4. G.-L. Hsu, “Emergent penile venous stripping for treating adolescent impotence,” Life, 2024.

5. G.-L. Hsu, “A case report of right cardiac ventricle perforation by uncontrolled embolization coil inserted for treating penile veno-occlusive dysfunction,” Urology Case Reports, 2022.

Lixin Yan | Pharmacology | Best Researcher Award

Mrs. Lixin Yan | Pharmacology | Best Researcher Award

Medical manager | Sinocelltech Ltd | China

Mrs. Lixin Yan is an accomplished medical manager with extensive experience in clinical research, specializing in oncology, infectious diseases, vaccines, and metabolic products. Over the years, she has led multiple Phase I–III clinical trials, contributing to protocol development, medical monitoring, feasibility assessment, and regulatory submissions. Her work has been instrumental in the clinical development of innovative therapies, including PD-1 inhibitors, EGFR-targeted treatments, HPV and COVID-19 vaccines, insulin, and GLP-1 products. She demonstrates strong expertise in GCP compliance, regulatory processes, and cross-functional team collaboration, ensuring high-quality research outcomes. Mrs. Yan has published impactful peer-reviewed articles, including first-author papers, highlighting her ability to generate reliable clinical evidence. Her dedication to advancing medical science through rigorous research and mentorship reflects her potential to lead future high-impact studies. Her measurable research impact is demonstrated through 68 citations, 5 documents, and an h-index of 4 according to Scopus.

Profile: Scopus

Featured Publications

1. L. Yan, J. Yi, D. Liu, J. Li, A. A. H. Baidoo, and L. Xie, “Efficacy and safety of SARS-CoV-2 neutralizing antibody, SCTA01, in high-risk outpatients diagnosed with COVID-19: A Phase II clinical trial,” Contemporary Clinical Trials Communications, 2025.